Changes of Endothelial Function Before and After DSA in Patients With Diabetes
NCT ID: NCT01556984
Last Updated: 2015-06-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
200 participants
OBSERVATIONAL
2012-10-31
2013-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Predictive Value of Sidestream Dark Field Imaging in Diabetic Nephropathy
NCT04403945
Validation Study of Coronary CT Angiography as a Screening Tool in Asymptomatic Diabetes
NCT00431977
The Effect of Intensive Multifactorial Therapy on Endothelial Function in Newly Diagnosed Type 2 Diabetes
NCT01101503
A Study to Evaluate Coronary Atherosclerosis in Patients With Diabetes Mellitus
NCT05801432
Mechanisms of Endothelial Dysfunction in Type 2 Diabetes
NCT02311075
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
DSA group
DSA assay
All patients with diabetic foot perform a DSA assay. Before and after DSA, endothelial function will be measured.
control group
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
DSA assay
All patients with diabetic foot perform a DSA assay. Before and after DSA, endothelial function will be measured.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 40 to 70 years old
Exclusion Criteria
* Renal failure
* Acute infection
40 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Wuhan General Hospital of Guangzhou Military Command
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Xiang Guang-da
Director of Wuhan General Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Wuhan General Hospital
Wuhan, Hubei, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
wz2010007
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.